BioNTech beats on earnings despite waning COVID vaccine demand

Yahoo Finance’s Anjalee Khemlani joins the Live show to discuss third-quarter earnings for BioNTech and news that the biotechnology company is raising the lower end of its full-year outlook for 2022.